Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
They don't want to pay OT hrs to have it done at night. <grin>
But since Vietnamese language is being referenced, maybe the web designer is in Asia and should easily be doing the work at our night hrs since it's their day.
Good info.
Hope ENDV gets it resolved soon.
They seem to be in a website update mode lately.
What is up with the ENDV website?
Endonovo is continuing to update the content of their website. You can now see how to order a Sofpulse device (with prescription).
BUT.....why is it when you Google Endonovo, the first link that appears is with a header title of BMW Mini R50/53 and Chinese looking characters?
The link will take you to Endonovo website without a problem. The Title/Header description line is messed up.
I see this from my phone and a computer.
Any IT guys with an explanation?
Interesting.
With BMIC on the Ask all day, I expected to see a T trade, but not a 300k "buy" T Trade.
Something must be brewing.
Brandon said they were too busy to talk to him last week.
It is now 6 trading days since they have filed a Form 4 and I have seen Mann's 1k buys (at least they appear to be). They are past due, per SEC rules, to have this form filed. Too busy to file the Form 4? A form that has been a regular task for the past year?
Hmmm. Maybe we have some news this week (crossing my fingers).
I jumped back in at $8.29
It's only been 1 year since the last 10-k (annual report) from ENDV came out still mentioning the licensing agreement.
I hope IPR did not pay $1m for nothing.
The agreement was supposedly made in 2011 and had 3 years to be finalized.
If it was never finalized, why mention it in a 2016 year end report? It already passed the 3 year termination timeframe.
Strange!!!
Any thoughts about ENDV merging with another company to assist with uplist to NASDAQ?
Could that possibility have anything to do with the crazy trading and MM activity we have seen?
I want to know how can we meet the asset requirement to be eligible for uplisting. Most people focus only on SP as the catalyst for uplisting, but more factors are involved.
Just thinking of some other explanations or discussion to bring to the board since discussions have slowed down.
I know the salesforce in Europe would be most definitely be for Sofpulse.
Just looking for confirmation ENDV is also going to continue with the licensing agreement for sales of CPAIR. CPAIR has not been mentioned in the financial reports anymore. I suspect is due to the fact CPAIR has been slow to get their units manufactured.
Definitely would be good to have multiple items for the salespeople to peddle. We need revenue.
Thanks. Looking at that document, i also saw the Pre14A.
What is the deal with increasing the AS?
When will that be determined?
What is the current O/S?
OTC Markets is not updated.
Wow...was up nice pre market and is now red
1. Ask how can ENDV uplist with our market cap so low? We need a valuation of $160m. Also need assets of greater than $80m. How do they place a value on the patents they own?
2. What is the timeframe of the redesign of the acquired PEMF assets? When can we expect the human concussion clinicals to start?
3. CPAIR, Inc. Has finally moved forward with the manufacturing of their device. Does ENDV still have the license to sell Internationally? They stopped mentioning them in the financials but they may be due to the fact the CPAIR was stagnant for so long.
4. What is the next step with the heart device? Pre-clinicals are completed. Now what? Redesign for human heart testing? Plans for human clinicals?
Finally. What is driving this?
That is great news about the O/S count. Dilution was cut in half the avg rate. Only 1 mill in 1 week compared to the 2 mill avg.
We are still within the timeframe of Form 4 reporting. Today is the 4th trading day since the last Form 4. 5 days is usually the max timeframe, although we have gone 6 trading days somewhat recently. I have seen the familiar 1k buys so I believe Mann is still buying away.
Definitely a good sign to hear Steve say he is "way too busy".
I want to provide a question or 2 to add to your list of questions if you don't mind. Just need to remember what they were and get back to you.
I'm right there with you.
Also very frustrating to read all the stock news articles proclaiming how UNDERvalued ENDV is.
OTCX playing peek-a-boo on L2.
Flashes on and off.
And with AEXG right behind, seems .04 will be our ceiling today.
The problem is the financials show a list of notes that can convert in the future but you can't track who is still holding or who has converted.
Endonovo has started making changes to their website to include the acquired technology.
Why is a rate hike gold positive?
Gold has no yield. An increase of interest rates makes bonds and money market accounts more attractive.
I'm not saying you're wrong. Just want your perspective.
When I first started trading JNUG last year, I watched my stop loss hit (on 2 occasions) to only then immediately watch the SP go up from my SL price.
Your statement is true!
It was walked down to my SL
Successful liver pre-clinical would be HUGE. But I don't have great hope for that any time soon. ENDV has been tinkering with the liver for quite some time now. Must not be as responsive as the heart.
At least we have concussion and MS study to distract us from the liver and kidney studies.
That OTCX MM seems to have popped up on other stocks recently also. We are not so special.
Same thing happened with VNDM. When it disappeared for us, it was the same with other stocks at the same time.
Oh well.....continue keeping any eye on ENDV from the crow's nest!
Now it appears on the Bid also
And it is only on the Ask side.
http://www.level2stockquotes.com/market-makers-o-list.html
Is a "Nasdaq Participant" ???
According to the MP type
BMIC gone from L2.
No longer competing with AEXG.
As in........
What is the timeframe for the redesigning of the PEMF assets to start the human concussion trials?
We know timeframes are not given to us.....next....
What is the next step with the heart and critical limb ischemia now that successful pre clinicals have concluded?
This could be given to us without a timeframe. At least it would be something.
We sit and wait and watch the slow...painful...drop of SP.
Those stories are from December.
You know something more recent?
Good luck on your next investment/trade.
You were lucky to have purchased at a very low SP and sell today at no loss.
You did make someone else happy by purchasing your sell order.
Who in the Hell is dumping 315k shares at .038 avg? SMH
The avg dilution rate has been 2 million shares weekly, even before the acquisition. It has been pretty consistent.
They need more money now than before. I'm surprised the dilution has not been worse.
They are redesigning the PEMF assets to be better prepared for human clinicals. Perhaps with the preclinical of the heart and ischemia now stopped, that money is being used to prepare for the human clinicals.
BMIC quick to jump in front of the retail sellers. NITE will need some patience to get those shares sold.
My guess is MM manipulation/games. Just adds another nice focal point for the ShareIntel analysis.
We all need to maintain our hopes for a turnaround here.
Sometimes it takes a reset of the expectations....like the start of a new football season.
Strangeness indeed!
Only guess I can make is that someone placed a Market Buy order, and the MM sold at this high price.
The OTC market is a "best offer" market. MM is not required to honor the offer price on L2. They can adjust the selling price even if receiving at the current Ask.
If this really happened, of course the MM would wait until market close to report it.
That study was done in 2007 by Ivivi.
We acquired the technology from Rio Grande.
Speaking of patents, here is a link describing the patents of CPAIR INC. of which we have the international licensing agreement.
https://patents.justia.com/assignee/cpair-inc
Using the money to redesign RGN assets for use in the clinical trials.
Question is "when" will they be ready for action.
With the redesign, will this involve new patent applications for the redesigns?
Will ENDV want to file those patent applications prior to clinical trials or after trial is proven effective?
Still waiting for the patent application from May 2017 to have updated status....Zzzzzzz
Some buying coming in at these low prices.
BMIC moved up on the Ask.
Now we need AEXG to scram to get some upward movement.
Form 4 skipped days.
It appears Mann did not purchase on 2/21 nor 2/22 (unless a Form 4 is late).
There were no PRs anywhere close to those dates.